Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2007

01-12-2007 | Case report

Minocycline

Hyperpigmentation: 4 case reports

Published in: Reactions Weekly | Issue 1/2007

Login to get access

Excerpt

Three women and one girl developed subcutaneous hyperpigmentation after treatment with minocycline [therapeutic indications, dosages and durations of treatment not stated]. …
Literature
1.
Bowen AR, McCalmont TH.The histopathology of subcutaneous minocycline pigmentation. Journal of the American Academy of Dermatology 57: 836-839, No. 5, Nov 2007 - USA
Metadata
Title
Minocycline
Hyperpigmentation: 4 case reports
Publication date
01-12-2007
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2007
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-200711820-00084

Other articles of this Issue 1/2007

Reactions Weekly 1/2007 Go to the issue

Clinical study

Paediatric patients at risk for glucocorticoid-induced osteoporosis benefit from treatment with alendronic acid

Case report

Methylprednisolone/prednisone

Case report

Sertindole

Case report

Acetic acid

Case report

Diamorphine

Case report

Sevoflurane